Browse News
Filter News
Found 11,738 articles
-
GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US
6/1/2023
GSK plc announced the launch of the COiMMUNITY Initiative to help reduce health inequities and set a new precedent for adult immunization rates in the US, which continue to remain below pre-pandemic levelsi.
-
$3.06Bn by 2027, Pharmaceutical Continuous Manufacturing Market Size, 9.8% CAGR Lead by Integrated Systems - Exclusive Research Report by The Insight Partners
6/1/2023
According to our new research study on “Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Integrated Systems, Semi-Continuous Systems, Controls); Application
-
Almaden Genomics Names Board of Advisors
5/31/2023
Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI.
-
Protein Binding Assay Market ($694.63 Million by 2028) Growth Forecast at 10.7% CAGR During (2021-2028) – The Insight Partners
5/31/2023
According to our new research study on “Protein Binding Assay Market to 2028 – Global Analysis and Forecast – by Technology, End User, and Geography,” the Protein Binding Assay Market Size is projected to reach US$ 694.63 million by 2028 from US$ 340.14 million in 2021; it is expected to grow at a CAGR of 10.7% during 2021–2028.
-
Peptide Therapeutics Market (Type, Application) to Outstrip $50,003.15 Million by 2027 Growing Sturdy at 9.2% CAGR – The Insight Partners
5/31/2023
According to our new research study on “Peptide Therapeutics Market to 2027 – Global Analysis and Forecast – by Type, Route of administration, Synthesis Technology, and Application,” the Peptide Therapeutics Market Size was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027;
-
Gastrointestinal Drugs Market (Type, Application) Growth Sturdy at 4.9% CAGR to Outstrip $71,300.28 Million by 2027 – The Insight Partners
5/31/2023
According to our new research study on “Gastrointestinal Drugs Market to 2027 – Global Analysis and Forecast – by Drug Class, Route of Administration, Application, and Distribution Channel,” the Gastrointestinal Drugs Market Size was valued at US$ 49,043.38 million in 2019 and is projected to reach US$ 71,300.28 million by 2027;
-
Virology Market (Type, Application) Valuation to Outstrip $5.27Bn by 2028 Growth Projection at 3.6% CAGR During 2021 to 2028 | The Insight Partners
5/31/2023
According to our latest study on “Virology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, End User, and Geography,” the Virology Market is projected to reach US$ 5,276.48 million by 2028 from US$ 4,108.27 million in 2021;
-
Cancer Vaccines Market to reach USD 15.84 Billion by 2027 Says, The Insight Partners
5/30/2023
According to our new market research study on "Cancer Vaccines Market to 2027 – Global Analysis and Forecast by Technology, Type, Indication, and End User," the market is expected to reach US$ 15,845.59 million by 2027 from US$ 4,568.82 million in 2019
-
$12+ Billion Influenza Vaccines Market to Grow at 7+% CAGR, Globally, by 2028 Lead by Quadrivalent Vaccines Segment with 88.36% Market Share in 2022 | The Insight Partners
5/30/2023
The Insight Partners published latest research study on "Influenza Vaccines Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028
-
Human Microbiome Market Size Worth $2.92Bn by 2028 at 22.2% CAGR Led by Probiotics Products (24.71% Market Share in 2021) Global Analysis by The Insight Partners
5/30/2023
The Insight Partners published latest research study on "Human Microbiome Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs and Supplements)
-
Typhoid Fever Vaccines Market to Grow at 9.3% CAGR During 2020 to 2027 – The Insight Partners
5/30/2023
According to our new market research study on “Typhoid fever vaccines Market to 2027 – Global Analysis and Forecas
-
HPV Vaccine Market: 5.73Bn by 2028, Human Papillomavirus Vaccine Market (Type, Dosage) Growing at 5% CAGR Lead by 9-Valent HPV Vaccine Segment, Global Analysis by The Insight Partners
5/26/2023
The Insight Partners published latest research study on “Human Papillomavirus (HPV) Vaccine Market Size, Share, Growth, Revenue, Trends, Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (9-Valent HPV Vaccine, Quadrivalent HPV Vaccine
-
Kidney Disease Market to Grow at 6.5% CAGR to be Worth $133.44Bn, Globally, by 2027 - Exclusive Report by The Insight Partners
5/26/2023
According to the new market research report "Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Diagnosis, Treatment)
-
Asthma Drugs Market (Medications, Route of Administration) Reach $34.13Bn, by 2028 at 5% CAGR with Quick Relief Medications Segment Driving Growth During 2021-2028 | The Insight Partners
5/26/2023
The Insight Partners published latest research report on "Asthma Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Medications, Route of Administration, and Distribution Channels”,
-
Drug Delivery Market (Route of Administration, Distribution Channel) - Reach $3254.59Bn by 2028 at 7.7% CAGR with Topical Drug Delivery Segment Driving Growth During 2023 –2028 | The Insight Partners
5/24/2023
The Insight Partners published latest research report on "Drug Delivery Market Growth Report, Size, Share, Trends & Growth Forecast to 2028 - COVID-19 Impact and Global Analysis By Route of Administration, Distribution Channel and End User”, the global market size is expected to grow from USD 20,99,856.7 million in 2022 to USD 32,54,594.2 million by 2028; it is estimated to record a CAGR of 7.7% from 2023 to 2028.
-
Sanofi and Regeneron reported positive results for the anti-inflammatory drug in a chronic obstructive pulmonary disease trial. The companies hope to see approval before a 2024 read-out of a second trial.
-
G1 Therapeutics Announces Appointment of Monica Thomas as General Counsel
5/22/2023
G1 Therapeutics, Inc., a commercial-stage oncology company, announced the appointment of Monica Thomas as its General Counsel and Chief Compliance Officer.
-
Influenza Vaccines Market (Vaccine Type, Virus Type) - Reach $12.27Bn by 2028 at 7.4% CAGR with Quadrivalent Vaccine Segment Driving Growth During 2022–2028 | The Insight Partners
5/22/2023
The Insight Partners published latest research report on "Influenza Vaccines Market Size Report, Share, Trends, Growth, Demand & Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group”, the global market size is projected to reach USD 12,272.49 million by 2028 from USD 7,478.53 million in 2021
-
Sania Therapeutics launches to advance novel medicines for neural circuit dysfunction
5/17/2023
Sania Therapeutics launches today by unveiling its suite of proprietary patented platforms at the American Society of Gene & Cell Therapy (ASGCT) conference.
-
The U.S. Supreme Court’s denial of Teva Pharmaceuticals’ appeal could have broad ramifications for the wider generics industry, for which “skinny labeling” is a common and accepted practice.